Ceres receives U.S. patent

Ceres Inc. (Nasdaq: CERE) received a U.S. patent for a genetic sequence derived from soybean sending the stock price soaring $1.25 to close at $2.93.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.